Completed

A Study of Olaratumab (LY3012207), Doxorubicin, and Ifosfamide in Participants With Advanced or Metastatic Soft Tissue Sarcoma

I5B-MC-JGDR - ClinicalTrials.gov - NCT03283696

The purpose of this study is to evaluate the safety of ifosfamide when added to olaratumab and doxorubicin in participants with soft tissue sarcoma (STS) that is advanced or has spread to another part(s) of the body.
How long will I be in the trial?
Your participation could last up to 16 weeks, depending on how you and your tumor respond
Email
Completed

A Study of Olaratumab (LY3012207), Doxorubicin, and Ifosfamide in Participants With Advanced or Metastatic Soft Tissue Sarcoma

I5B-MC-JGDR - ClinicalTrials.gov - NCT03283696

The purpose of this study is to evaluate the safety of ifosfamide when added to olaratumab and doxorubicin in participants with soft tissue sarcoma (STS) that is advanced or has spread to another part(s) of the body.
How long will I be in the trial?
Your participation could last up to 16 weeks, depending on how you and your tumor respond
Email

Key Requirements

Age :

18+

Sex:

All

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18+

Sex

All

Participants must

Participants must NOT

Trial Summary

Conditions the trial is for

Soft Tissue Sarcoma

What the trial is testing?

interventions example

Could I receive a Placebo?

no

Enrollment Goal

45

Trial Dates

October 2017 - August 2019

Trial Phase

1

Enter your postal code to find the nearest site

Key Requirements

Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.

Age

18+

Sex

All

Participants must

Participants must NOT

Trial Summary

Conditions the trial is for

Soft Tissue Sarcoma

What the trial is testing?

interventions example

Could I receive a Placebo?

no

Enrollment Goal

45

Trial Dates

October 2017 - August 2019

Trial Phase

1

Not the right fit? Sign up to receive updates on new trials.

Trial Locations

Hide locations not currently recruiting

Enter your postal code to see sites near you

Soft Tissue Sarcoma Resources

Clinical Trial Participation: What to Expect

Clinical Trial Participation: What to Expect

A clinical trial is a scientific study in people that helps to determine if and how a drug or therapy works. These can also be called clinical studies, or clinical research. Clinical research helps us answer specific questions about an investigational drug , such as: Is it effective? Is it more effective than another established treatment? Is it safe and/or what are its side effects?